Skip to content

MEC90 for Supra-inguinal Fascia Iliaca Block Performed Under Ultrasound Guidance in Arthroscopic Knee Surgery

Minimum Effective Concentration (MEC90) for Supra-inguinal Fascia Iliaca Block Performed Under Ultrasound Guidance in Arthroscopic Knee Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05408585
Enrollment
65
Registered
2022-06-07
Start date
2022-06-07
Completion date
2023-02-27
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Brief summary

In this study, the minimum effective concentration required for supra-inguinal fascia iliaca block applied in patients undergoing arthroscopic knee surgery is aimed. The same volume will be used in all of the block applications in the study, and the local anesthetic concentration used will be determined by increasing or decreasing according to the success of the previous block. The primary goal of the study is block success.

Detailed description

For patients included in the study, 40 mL of local anesthetic will be used for SIFIB. The local anesthetic concentration will be randomized using the biased-coin design up-down sequential method, as suggested by Durham et al. and described by Dixon. The primer outcome of this study is block success. Also, the incidence of motor block formation in the quadriceps muscle (to be defined as paresis or paralysis in knee extension), the amount of tramadol needed in 24 hours, opioid-related side effects (postoperative nausea/vomiting, itching), length of hospital stay and complications that may develop related to the block will be recorded.

Interventions

OTHERRegional Anesthesia Techniques

Fascial Plane Blocks

Sponsors

Samsun Education and Research Hospital
CollaboratorOTHER
Samsun University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

All blocks will be performed by the same experienced anesthetist to ensure block quality and homogeneity. The anesthetist applying the block will not take part in the patient follow-up, the independent assistant following the patient will be blinded to the study.

Intervention model description

As suggested by Durham et al and described by Dixon, study randomization will be performed using the biased-coin design up-down sequential method.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing arthroscopic knee surgery under spinal anesthesia will be included in the study.

Exclusion criteria

* Conditions where regional anesthesia is contraindicated (coagulopathy, infection..) * Patients who underwent general anesthesia for the surgical procedure * Patients who do not want to be included in the study by not signing the voluntary consent form. * Patients with advanced dementia, orientation-cooperation problems * History of allergy to local anesthetic drugs * Infection status at the injection site

Design outcomes

Primary

MeasureTime frameDescription
Block Successat 6, 12, 24 hoursBlock success will be evaluated on the post-operative period in the antrior and lateral of thigh using pinprick test.

Secondary

MeasureTime frameDescription
Tramadol Consumption24 hoursTramadol Consumption in 24 hours

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026